Testing effectiveness (Phase 2)Looking for participantsNCT05852730
What this trial is testing
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Who this might be right for
Motion Sickness, SpaceMotion SimulationParabolic Flight
Repurposed Therapeutics, Inc. 80